These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38727931)

  • 1. Effects of CD44 siRNA on inhibition, survival, and apoptosis of breast cancer cell lines (MDA-MB-231 and 4T1).
    Dehbokri SG; Noorolyai S; Baghbani E; Moghaddamneshat N; Javaheri T; Baradaran B
    Mol Biol Rep; 2024 May; 51(1):646. PubMed ID: 38727931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468).
    Vahidian F; Safarzadeh E; Mohammadi A; Najjary S; Mansoori B; Majidi J; Babaloo Z; Aghanejad A; Shadbad MA; Mokhtarzadeh A; Baradaran B
    Mol Biol Rep; 2020 Dec; 47(12):9541-9551. PubMed ID: 33206362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
    Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
    Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ; Jiang H; Zhao XP; Jiang WM
    BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
    Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
    Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of miR-143 expression could inhibit migration and growth of MDA-MB-468 cells through down-regulating the expression of invasion-related factors.
    Tavanafar F; Safaralizadeh R; Hosseinpour-Feizi MA; Mansoori B; Shanehbandi D; Mohammadi A; Baradaran B
    Biomed Pharmacother; 2017 Jul; 91():920-924. PubMed ID: 28511343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
    Mohammadzadeh R; Saeid Harouyan M; Ale Taha SM
    Tumour Biol; 2017 Mar; 39(3):1010428317695925. PubMed ID: 28349828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.
    Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Vellon L; Menendez JA
    Cell Cycle; 2011 Nov; 10(22):3871-85. PubMed ID: 22127234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CD44 inhibits proliferation, migration, and invasiveness in hepatocellular carcinoma cells by modulating CXCR4/Wnt/β-Catenin Axis.
    Song X; Ding F; Luo W; Tao J; Yang K; Li Q; Zhang Z
    Acta Biochim Pol; 2023 Feb; 70(1):117-122. PubMed ID: 36735564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
    Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
    J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12 modulates the radiosensitivity of cervical cancer by regulating CD44.
    Fu Z; Zhang P; Luo H; Huang H; Wang F
    Mol Med Rep; 2018 Dec; 18(6):5101-5108. PubMed ID: 30320394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
    Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
    Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
    Calaf GM; Ponce-Cusi R; Abarca-Quinones J
    Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of HMGA2 gene downregulation by siRNA on lung carcinoma cell migration in A549 cell lines.
    Naghizadeh S; Mansoori B; Mohammadi A; Kafil HS; Mousavi Z; Sakhinia E; Baradaran B
    J Cell Biochem; 2019 Apr; 120(4):5024-5032. PubMed ID: 30317663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of soluble E-selectin on tumor progression and metastasis.
    Kang SA; Blache CA; Bajana S; Hasan N; Kamal M; Morita Y; Gupta V; Tsolmon B; Suh KS; Gorenstein DG; Razaq W; Rui H; Tanaka T
    BMC Cancer; 2016 May; 16():331. PubMed ID: 27220365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.